Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
---|
02/03/2009 | US7485653 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease |
02/03/2009 | US7485651 Cholinergic agents such as 4-Butyl-1-(4-phenyl-4-oxo-1-butyl) piperidine, administered as cognition activators and for prophylaxis of vision defects |
02/03/2009 | CA2441613C Novel amlodipine camsylate and method for preparing thereof |
02/03/2009 | CA2425164C (4-acylaminopiperidin-1-yl)acetamides as neurokinin antagonists |
02/03/2009 | CA2410554C Use of (+)-.alpha. -(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol or its prodrug in the treatment of symptoms of dementia and dopamine induced psychosis |
02/03/2009 | CA2382435C Novel herbicidally active phenyl-substituted heterocycles |
02/03/2009 | CA2315050C Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereof |
02/03/2009 | CA2282654C Use of cholinesterase inhibitors to treat attention deficit hyperactivity disorder |
01/29/2009 | WO2009015166A1 Piperidine derivatives as modulators of chemokine receptor activity |
01/29/2009 | WO2009014997A2 Immobilization of dyes and antimicrobial agents on a medical device |
01/29/2009 | WO2009013299A2 Novel bradykinin b1 antagonists |
01/29/2009 | WO2009013293A1 Substituted cyclohexanecarboxamides useful as bace inhibitors |
01/29/2009 | WO2007144769A8 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics |
01/29/2009 | US20090030174 One-pot, one-step in situ living polymerization from silicate anchored multifunctional initiator |
01/29/2009 | US20090029991 Benzamide derivatives useful as histone deacetylase inhibitors |
01/29/2009 | US20090029971 4-[2,6-Dimethyl-4-(4-trifluoromethoxy-phenyl)-piperazine-1-sulfonyl]-indan-2-carboxylic acid; peroxisome proliferator activated receptors modulator; antidiabetic, antiinflammatory agent; obesity, hyperinsulinemia, metabolic syndrome X, polycystic ovary syndrome, ischemia-associated organ injury |
01/29/2009 | US20090028904 Novel cochleate formulations |
01/29/2009 | CA2694251A1 Novel b1-antagonists |
01/29/2009 | CA2694224A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
01/29/2009 | CA2693500A1 Immobilization of dyes and antimicrobial agents on a medical device |
01/28/2009 | EP2018166A2 Terephthalamate compounds and compositions, and their use as hiv integrase inhibitors |
01/28/2009 | EP1670761B1 Tetrahydro-naphthalene and urea derivatives |
01/28/2009 | EP1542687B1 Small organic molecules that increase the activity of gelatinase a in ocular cells |
01/28/2009 | EP1446400B1 Piperidine derivatives, process for preparation thereof, and pharmaceutical composition for alzheimer's disease containing the same |
01/28/2009 | EP1315701B1 Process for the racemisation of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2,3,6-tetrahydropyridine to be used as intermediate in the synthesis of paroxetine |
01/28/2009 | CN101356156A Aspartic protease inhibitors |
01/28/2009 | CN101356155A Phenoxy acetic acids as PPAR-delta activators |
01/28/2009 | CN101355951A Novel opioid antagonists |
01/28/2009 | CN101353446A Manufacturing method of light-stability agent |
01/28/2009 | CN101353321A 3-amino-piperadine derivatives and methods of manufacture |
01/28/2009 | CN100455566C Novel derivatives of aminocyclohexane |
01/27/2009 | US7482472 Such as 2-(4-[[(5-chloro-2-thienyl)carbonyl]amino]-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetic acid; blood coagulation; treating thromboembolic disorders (myocardial infarction, angina pectoris, reocclusions and restenoses after angioplasty/aortocoronary bypass, stroke), atherosclerosis and arthritis |
01/27/2009 | US7482466 Hydroxamates as therapeutic agents |
01/27/2009 | US7482464 in dimethyl sulfoxide from (R,S)-amlodipine on an industrial scale using L-(+)-tartaric acid which is much cheaper than D-(-)-tartaric acid; (S)-(-)-amlodipine-hemi-L-tartrate-1/4-DMSO-solvate claimed |
01/27/2009 | US7482462 Immunosuppressants for treating skin disorders, acne, alopecia, estrogen- or androgen-dependent tumors, rheumatoid arthritis, type I and II diabetes, lupus erythematosus, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriasis, contact dermatitis, graft versus host disease, eczema, asthma |
01/27/2009 | US7482461 3-(1-methylpiperidin-4-yl)-5-(1-naphthylsulfonyl)-1H-indazole, central nervous system disorder |
01/27/2009 | US7482365 Piperidylcarboxamide derivatives and their use in the treatment of tachykinin-mediated diseases |
01/27/2009 | US7482364 Histamine H3 antagonists; do not contain imidazolyl moiety; such as 1-[4-(4-piperidin-1-ylmethyl-phenyl)-but-3-ynyl]-piperidine |
01/27/2009 | US7482363 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of respiratory system disorders or as antiallergens |
01/27/2009 | US7482347 CCR-3 receptor antagonists; inflammatory or allergic condition such as asthma or obstructive airway disease; 1-[1-(3,5-Dimethylisoxazole-4-sulfonyl)-piperdin-4-yl-methyl]-4-(4-fluorobenzyl)-piperazine; 1-(4-Fluorobenzyl)-4-(4-piperidinylmethyl) piperazine intermediate and a sulfonyl halide reactant |
01/27/2009 | US7482335 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents |
01/22/2009 | WO2009011653A1 A process for the preparation of intermediates and their us in the synthesis of spiropiperidine compounds |
01/22/2009 | WO2009010660A2 Substituted indazoles, the preparation thereof, and use of same in therapeutics |
01/22/2009 | WO2009010480A1 1-{2-[(diphenyl)amino]-ethyl}-piperidine-4-carboxylic acid benzylamide derivatives and related compounds as ccr5 agonists for the treatment of immune and inflammatory diseases |
01/22/2009 | WO2009010478A2 Use of piperidine derivatives as agonists of chemokine receptor activity |
01/22/2009 | WO2009010477A1 Piperidine-4-acetic acid derivatives and their use |
01/22/2009 | WO2009009812A1 Pleuromutilin derivatives and their use as antimicrobials |
01/22/2009 | WO2008070697A4 Stat3 inhibitor having anti-cancer activity and associated methods |
01/22/2009 | US20090023926 Biopolymer ionization; liquid chromatography |
01/22/2009 | US20090023918 Process for preparing 3-acylaminobenzofuran-2-carboxylic acid derivative |
01/22/2009 | US20090023917 Selective Estrogen Receptor Modulators for the Treatment of Vasomotor Symptoms |
01/22/2009 | US20090023777 Substituted 4-amino-benzylpiperidine compounds |
01/22/2009 | US20090023734 Treating cell proliferative disorders |
01/22/2009 | US20090023733 Piperidine Derivatives, Their Process for Preparation, Their Use as Therapeutic Agents and Pharmaceutical Compositions Containing Them |
01/22/2009 | US20090023730 such as 1-(3-tert-butyl-1-methyl-1H-pyrazole-5-carbonyl)-3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thiourea; packages, patches; hepatitis virus infections |
01/22/2009 | US20090023718 Diamine and Iminodiacetic Acid Hydroxamic Acid Derivatives |
01/22/2009 | US20090023711 Piperazines and Piperidines as Mglur5 Potentiators |
01/22/2009 | US20090023710 Compound |
01/22/2009 | US20090023664 protease inhibitors such as 5-(dimethylamino)-N-[(2S,3R)-3-hydroxy-4-[(4-methoxyphenyl)sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-2-methylbenzamide, used for for treating human immunodeficiency virus (HIV) infections |
01/22/2009 | CA2693015A1 Pleuromutilin derivatives and their use as antimicrobials |
01/21/2009 | EP2016941A1 Transdermally absorbable donepezil preparation |
01/21/2009 | EP0951466B1 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
01/21/2009 | CN101351449A Nitroxyl compound, and polymerization inhibitor and polymerization inhibitor composition using same |
01/21/2009 | CN101351448A Novel 1 -benzyl-4-piperidinamines that are useful in the treatment of COPD and asthma |
01/21/2009 | CN101351447A Organic compounds and manufacture thereof |
01/21/2009 | CN101351204A Novel arylamidine derivative, salt thereof and antifungal agent containing those |
01/21/2009 | CN101348824A Neurocyte protective agent |
01/21/2009 | CN101348458A Synthetic method of nisoldipine photolytic product reference substance |
01/21/2009 | CN101348457A Tetrahydrochysene pyridine quaternary ammonium salt and synthetic method thereof |
01/21/2009 | CN101348456A Benzyl piperidine coumpound, and preparation and use thereof |
01/20/2009 | US7479573 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell |
01/20/2009 | US7479571 Generation of combinatorial synthetic libraries and screening for novel proadhesins and nonadhesins |
01/20/2009 | US7479563 Method of producing polymorphic crystals of donepezil hydrochloride |
01/20/2009 | US7479562 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects of dry-mouth and constipation; biphenyl carbamate derivatives; biphenyl-2-ylcarbamic acid 1-(3-(3-[3-(4-hydroxybenzylamino)propyl]-2-oxoimidazolidin-1-yl)propyl)piperidin-4-yl ester |
01/20/2009 | US7479559 3-[-2-(Piperazin-1-yl)benzyl]pyrrolidin-2-one derivatives; antidepressants, anxiolytic agents; obsessive compulsive disorder, psychological disorders, phobias; 5-HT1 agonist or antagonists; side effect reduction, in particular cardiac QTc prolongation; hydrogenation |
01/20/2009 | US7479530 Comprising one or more macromonomer units selected from perfluoroalkylpolyether, fluorinated poly(meth)acrylate, poly(perfluoroalkyl) (meth)acrylate, poly(fluoroalkyl) (meth)acrylamide, and fluorinated polyolefin, and one or more charged units; intraocular lenses |
01/20/2009 | US7479491 Azanthranylalkyl and -cycloalkyl amides and their use as VEGF receptor inhibitors |
01/20/2009 | CA2521030C 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors |
01/20/2009 | CA2337770C Amide derivatives which are useful as cytokine inhibitors |
01/15/2009 | WO2009008508A1 Antitumor agent comprising sulfostin and sulfostin-related compound as the active ingredient |
01/15/2009 | WO2009007396A1 Nonsteroidal progesterone receptor modulators |
01/15/2009 | WO2009007015A1 Malonamide derivatives with antithrombotic activity |
01/15/2009 | WO2008101914A3 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
01/15/2009 | WO2008097546A3 Compounds that inhibit cholinesterase |
01/15/2009 | US20090018167 angiogenesis inhibitors such as 1-phenyl-3-pyridin-2-ylprop-2-en-1-one, having antitumor and anticarcinogenic activity; treatment of skin disorders such as psoriasis, acne, rosacea, warts, eczema, hemangiomas, and lymphangiogenesis, as well as chronic inflammatory disease such as arthritis |
01/15/2009 | US20090018165 Biphenyl compounds useful as muscarinic receptor antagonists |
01/15/2009 | US20090018143 Thio-substituted arylmethanesulfinyl derivatives |
01/15/2009 | US20090018132 Substituted Heterocyclic Ethers and Their Use in CNS Disorders |
01/15/2009 | US20090018116 Therapeutic Compounds |
01/15/2009 | US20090018103 Diaminoalkane Aspartic Protease Inhibitors |
01/15/2009 | US20090018054 Cholesteryl Ester Transfer Protein Inhibitors |
01/15/2009 | US20090017489 Methods For Modulating The Development Of Dopamine Neuron By The Dopamine D2 Receptor And Compositions Thereof |
01/15/2009 | DE102007032800A1 Nichtsteroidale Progesteronrezeptor-Modulatoren Non-steroidal progesterone receptor modulators |
01/15/2009 | CA2695330A1 Inhibitors of akt/pkb with anti-tumor activity |
01/15/2009 | CA2693396A1 Malonamide derivatives with antithrombotic activity |
01/14/2009 | EP2014645A1 Pleuromutilin derivatives and their use as antimicrobials |
01/14/2009 | EP2014285A1 NPYY5 antagonists |
01/14/2009 | EP2013197A1 Phenethanolamine derivatives as beta2 adrenoreceptor agonists |
01/14/2009 | EP2013172A1 New alkyl esters of cyclic amino alcohols with muscarinic m3 receptor antagonist activity, useful for treating e.g. chronic bronchial obstruction, asthma and overactive bladder |
01/14/2009 | EP2013171A1 Piperidines and related compounds for treatment of alzheimer s disease |